Paul Bilzerian has been on the run from the Securities and Exchange Commission for so long that he now owes the agency $180 ...

CEL-SCI believes that boosting a patient’s immune system while it is still intact should provide the greatest possible impact ...

Victims including 38,860 individuals, as well as schools, charities and pension plans, will have recouped an average 93.71% ...

OS Therapies, Inc. (NYSE-A: OSTX) (“OS Therapies” or the “Company”), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology c ...

The Colombo Stock Exchange (CSE) and the Securities and Exchange Commission of Sri Lanka (SEC) in association with the Stock ...

A FINRA arbitration panel sided with a claimant who contended Wells and one of its advisors should have recognized telltale ...

Anbio Biotechnology filed for a 1.6 million-share initial public offering with the Securities and Exchange Commission. The company said Tuesday it expects the IPO to price between $5 and $6 per share, ...

A federal circuit court recently vacated a U.S. Securities and Exchange Commission (SEC) order approving Nasdaq’s diversity rule for boards ...

The new $467 million includes $400 million in royalties for the Pfizer-BioNTech vaccine from 2020 through 2023.

Oak Row Equities is under purchase contract for $520 million for Aimco’s 4.3-acre bayfront Brickell assemblage.

The Division of Economic and Risk Analysis (DERA) at the Securities and Exchange Commission (SEC) has provided an update ...

Shares of Biohaven (BHVN) gained in morning trade on Tuesday after the company’s director John W. Childs acquired shares ...